Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

72.32
+0.04000.06%
Post-market: 72.320.00000.00%19:30 EDT
Volume:3.96M
Turnover:286.20M
Market Cap:11.27B
PE:62.34
High:72.35
Open:72.32
Low:72.27
Close:72.28
52wk High:72.62
52wk Low:43.20
Shares:155.81M
Float Shares:155.81M
Volume Ratio:1.46
T/O Rate:2.54%
Dividend:0.32
Dividend Rate:0.44%
EPS(TTM):1.16
EPS(LYR):1.16
ROE:9.03%
ROA:6.26%
PB:5.34
PE(LYR):62.34

Loading ...

Bio-Techne Beats Revenue Estimates on Research, Diagnostics Demand Uptick

Reuters
·
Aug 12

Bio-Techne Q4 Revenue Rises 3%, Beats Estimates

Reuters
·
Aug 12

Bio-Techne Declares USD 0.08 Quarterly Dividend

Reuters
·
Aug 12

Bio-Techne Q4 Adjusted EPS USD 0.52 Vs. IBES Estimate USD 0.52

Reuters
·
Aug 12

Bio-Techne Q4 Operating Income USD 74.277 Million

THOMSON REUTERS
·
Aug 12

Bio-Techne Q4 EPS Usd 0.35

THOMSON REUTERS
·
Aug 12

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

THOMSON REUTERS
·
Aug 12

U.S. Earnings Preview: Before Market Open Aug. 12

Dow Jones
·
Aug 12

Bio-Techne (TECH) Stock Could Be 21% Above Fair Value On Earnings And Cash Flow

Simply Wall St.
·
Aug 08

Table: G-TECH Optoelectronics Jul Rev Nt$213.9m vs Nt$172.4m

Dow Jones
·
Aug 07

Merck Raises 2026 Profit Guidance, Beats Quarterly Estimates

Reuters
·
Aug 06

Cognizant Launches EMEA AI Unit to Scale Agentic AI Adoption Across Europe, Middle East, Africa

Reuters
·
Jul 28

Press Release: Groupe Dynamite Appoints AI and TECH Leader, MR. Martin KON, to ITS BOARD of Directors

Dow Jones
·
Jul 23

Repligen Beefs up Cell Therapy Business with $1.5 Billion Deal for Biolife

Reuters
·
Jul 22

Press Release: YSX TECH. CO. LTD Reports Full Year 2026 Financial Results

Dow Jones
·
Jul 11

RBC Capital Downgrades Bio-Techne to Sector Perform From Outperform, Adjusts Price Target to $73 From $62

MT Newswires Live
·
Jul 09

U.S. Research Roundup-applied Materials, CME Group, NASDAQ

Reuters
·
Jul 09

Bio-techne Corp : RBC Cuts to Sector Perform from Outperform; Raises Target Price to $73 from $62

THOMSON REUTERS
·
Jul 09

Bio-Techne Expands AI-Engineered Designer Protein Portfolio

MT Newswires Live
·
Jul 08

Evercore ISI Downgrades Bio-Techne to In Line From Outperform, Maintains $73 Price Target

MT Newswires Live
·
Jul 06